ICD-10-CM Billable Code

C82.30

Follicular lymphoma grade IIIa, unspecified site

Clinical Classification Guidelines

Medical Intelligence & Overview

Follicular lymphoma is a type of non-Hodgkin lymphoma, which is a cancer that begins in the lymphatic system. The term 'grade IIIa' describes the aggressiveness of the cancer, indicating a more advanced form with certain cellular features. This particular diagnosis, coded as C82.30 in the ICD-10 system, refers to follicular lymphoma that has a higher grade but occurs at unspecified locations in the body. Understanding this condition can help patients better grasp the nature of their diagnosis, treatment options, and prognosis.

Causes & Symptoms

Clinical Causes: Genetic mutations: Certain changes in the DNA of lymphocytes can lead to abnormal growth. Immune system factors: A weakened immune system may increase susceptibility. Environmental exposures: Although not definitively proven, exposure to certain pesticides or chemicals could potentially contribute. Age: The risk increases with advancing age, particularly in older adults. Family history: A family background of lymphomas can slightly raise the likelihood.

Key Symptoms: Swollen lymph nodes: Typically painless swelling in the neck, armpit, or groin. Fatigue: Feeling unusually tired or lacking energy. Unexplained weight loss: Significant weight reduction without changes in diet or activity. Fever: Persistent or recurrent fevers not related to infections. Night sweats: Severe sweating during sleep. Abdominal discomfort: Occasional pain or swelling due to lymph node enlargement in the abdomen. Itching: Generalized itching without an apparent cause.

Diagnostic & Treatment

Diagnosis Path: Physical examination: Checking for swollen lymph nodes or organ enlargement. Blood tests: Complete blood counts and other tests to assess overall health. Imaging tests: CT scans, PET scans, or MRIs to identify affected areas. Lymph node biopsy: A sample of lymph node tissue examined microscopically to confirm lymphoma type and grade. Bone marrow biopsy: To evaluate if the cancer has spread to the bone marrow.

Treatment Protocols: Chemotherapy: Using drugs to kill cancer cells, often combined with immunotherapy. Immunotherapy: Medications like monoclonal antibodies that help the immune system recognize and attack lymphoma cells. Targeted therapy: Drugs that target specific molecules involved in cancer growth. Radiation therapy: Focusing high-energy rays on affected lymph node regions. Watchful waiting: In certain cases with slow progression, immediate treatment may be deferred with regular monitoring.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C82.30 a billable ICD-10 code?
Yes, C82.30 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C82.30?
Clinical documentation must specify the nature of Follicular lymphoma grade IIIa, unspecified site and any associated comorbidities for accurate reporting.

Cite this Clinical Reference